LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 106 filers reported holding LEXICON PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $158,863 | -54.2% | 145,746 | -3.8% | 0.00% | – |
| Q2 2023 | $346,798 | +125.2% | 151,440 | +138.9% | 0.00% | – |
| Q1 2023 | $154,026 | +27.3% | 63,385 | +0.0% | 0.00% | – |
| Q4 2022 | $121,028 | +27.4% | 63,365 | +60.5% | 0.00% | – |
| Q3 2022 | $95,000 | +31.9% | 39,483 | +1.3% | 0.00% | – |
| Q2 2022 | $72,000 | -20.0% | 38,975 | -9.7% | 0.00% | – |
| Q1 2022 | $90,000 | -46.4% | 43,150 | +0.9% | 0.00% | – |
| Q4 2021 | $168,000 | -22.2% | 42,744 | -5.0% | 0.00% | – |
| Q3 2021 | $216,000 | +50.0% | 45,008 | +42.6% | 0.00% | – |
| Q2 2021 | $144,000 | +121.5% | 31,562 | +186.0% | 0.00% | – |
| Q1 2021 | $65,000 | -84.6% | 11,036 | -94.8% | 0.00% | – |
| Q2 2020 | $423,000 | +302.9% | 212,017 | +289.7% | 0.00% | – |
| Q1 2020 | $105,000 | -21.6% | 54,401 | +68.9% | 0.00% | – |
| Q4 2019 | $134,000 | +67.5% | 32,202 | +22.2% | 0.00% | – |
| Q3 2019 | $80,000 | -53.2% | 26,349 | -3.4% | 0.00% | – |
| Q2 2019 | $171,000 | +3.0% | 27,289 | -8.4% | 0.00% | – |
| Q1 2019 | $166,000 | -25.6% | 29,799 | -11.1% | 0.00% | – |
| Q4 2018 | $223,000 | -65.4% | 33,532 | -44.6% | 0.00% | -100.0% |
| Q3 2018 | $645,000 | -57.2% | 60,477 | -51.8% | 0.00% | 0.0% |
| Q2 2018 | $1,506,000 | +257.7% | 125,563 | +155.2% | 0.00% | – |
| Q1 2018 | $421,000 | -15.5% | 49,209 | -2.5% | 0.00% | – |
| Q4 2017 | $498,000 | -37.6% | 50,474 | -22.3% | 0.00% | -100.0% |
| Q3 2017 | $798,000 | -28.1% | 64,960 | -3.7% | 0.00% | 0.0% |
| Q2 2017 | $1,110,000 | -16.4% | 67,487 | -27.1% | 0.00% | 0.0% |
| Q1 2017 | $1,327,000 | +32.3% | 92,548 | +27.5% | 0.00% | 0.0% |
| Q4 2016 | $1,003,000 | -11.1% | 72,570 | +16.2% | 0.00% | 0.0% |
| Q3 2016 | $1,128,000 | +29.2% | 62,464 | +2.7% | 0.00% | 0.0% |
| Q2 2016 | $873,000 | -32.4% | 60,826 | -43.7% | 0.00% | -50.0% |
| Q1 2016 | $1,291,000 | +228.5% | 107,978 | +265.3% | 0.00% | – |
| Q4 2015 | $393,000 | +22.0% | 29,562 | -1.4% | 0.00% | – |
| Q3 2015 | $322,000 | -67.2% | 29,985 | -75.4% | 0.00% | -100.0% |
| Q2 2015 | $983,000 | – | 122,080 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $25,366,000 | 100.00% |
| Artal Group S.A. | 71,178,364 | $417,817,000 | 7.38% |
| BVF INC/IL | 8,394,000 | $49,273,000 | 1.85% |
| Boothe Investment Group, Inc. | 435,939 | $2,559,000 | 1.49% |
| Campbell & CO Investment Adviser LLC | 103,100 | $605,000 | 0.37% |
| NEA Management Company, LLC | 2,382,286 | $13,984,000 | 0.31% |
| PINNACLE ASSOCIATES LTD | 2,167,172 | $12,721,000 | 0.24% |
| Eversept Partners, LP | 410,593 | $2,410,181 | 0.18% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $210,000 | 0.12% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 66,299 | $389,000 | 0.08% |